| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $70.6M | $57.9M | $84.2M |
| YoY Revenue Growth % | +22.1% | -31.3% | — |
| Gross Profit | $44.1M | $34.3M | — |
| Gross Margin % | 62.4% | 59.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$34.1M | -$41.3M | -$26.9M |
| Operating Margin % | -48.2% | -71.5% | -32.0% |
| Net Income (GAAP) | -$31.6M | -$36.6M | -$19.7M |
| EBITDA (Normalized) | -$33.2M | -$39.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$12.7M | $1.0M | -$6.4M |
| Capital Expenditures (CapEx) | $1.1M | $1.9M | — |
| Free Cash Flow (FCF) | -$13.8M | -$848.0K | -$6.4M |
| FCF Margin % | -19.5% | -1.5% | -7.6% |
| Return on Invested Capital (ROIC %) | -34.9% | -30.4% | — |
| Cash & Short-Term Equivalents | $27.9M | $35.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $105.0M | $142.7M | — |